The California Institute for Regenerative Medicine (CIRM) has launched the $100 million RAPID program to accelerate the development and delivery of platform-based genetic therapies for rare diseases. Building on the…
Skyhawk Therapeutics Announces Nine Month Interim Results
A press release from Skyhawk Therapeutics announces nine month interim results in patients from its Phase 1 clinical trial of SKY-0515 as a treatment for Huntington’s Disease. See the full…
Menifee City Disabilities Fair
The Menifee City Disabilities Fair, sponsored by the city of Menifee November 8th, 2025: UCI HD-CARE board member Leslie Frias was there to raise awareness for Huntington Disease research at…